| Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors AH Nassar, E Adib, S Abou Alaiwi, T El Zarif, S Groha, EW Akl, PV Nuzzo, ... Cancer Cell 40 (10), 1161-1172. e5, 2022 | 68 | 2022 |
| Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study H El-Khoury, DJ Lee, JB Alberge, R Redd, CJ Cea-Curry, J Perry, H Barr, ... The Lancet Haematology 9 (5), e340-e349, 2022 | 41 | 2022 |
| Single cell characterization of myeloma and its precursor conditions reveals transcriptional signatures of early tumorigenesis R Boiarsky, NJ Haradhvala, JB Alberge, R Sklavenitis-Pistofidis, ... Nature Communications 13 (1), 7040, 2022 | 38 | 2022 |
| Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study A Cowan, F Ferrari, SS Freeman, R Redd, H El-Khoury, J Perry, V Patel, ... The Lancet Haematology 10 (3), e203-e212, 2023 | 28 | 2023 |
| Implementation of pharmacogenetics to individualize treatment regimens for children with acute lymphoblastic leukemia D Maamari, H El-Khoury, O Saifi, SA Muwakkit, NK Zgheib Pharmacogenomics and Personalized Medicine, 295-317, 2020 | 19 | 2020 |
| Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenström macroglobulinemia S Tahri, TH Mouhieddine, R Redd, L Lampe, KI Nilsson, H El-Khoury, ... Blood Advances 6 (7), 2230-2235, 2022 | 11 | 2022 |
| Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: A prospective cohort study H El-Khoury, DJ Lee, JB Alberge, R Redd, CJ Cea-Curry, J Perry, H Barr, ... | 6 | 2021 |
| High prevalence of monoclonal gammopathy in a population at risk: the first results of the Promise study H El-Khoury, JB Alberge, H Barr, C Murphy, DJ Sakrikar, T Krause, ... Blood 138, 152, 2021 | 6 | 2021 |
| Clonal Hematopoiesis Is Associated with Increased Risk of Progression of Asymptomatic Waldenström Macroglobulinemia S Tahri, TH Mouhieddine, RA Redd, LM Lampe, K Nillson, NK Su, ... Blood 138, 2678, 2021 | 5 | 2021 |
| Treatment‐induced cerebral sinus venous thrombosis in childhood acute lymphoblastic malignancies: new risk factors to consider H El‐Khoury, O Saifi, S Haddad, M Chahrour, KM Ghanem, Y Mubarak, ... Pediatric Blood & Cancer 68 (11), e29210, 2021 | 5 | 2021 |
| A GRIN3A polymorphism may be associated with glucocorticoid-induced symptomatic osteonecrosis in children with acute lymphoblastic leukemia NK Zgheib, H El-Khoury, D Maamari, M Basbous, R Saab, SA Muwakkit Personalized Medicine 18 (05), 431-439, 2021 | 4 | 2021 |
| Association of preoperative systemic corticosteroid therapy with surgical outcomes in chronic obstructive pulmonary disease patients S Abou Arbid, H El-Khoury, F Jamali, H Tamim, H Chami Annals of Thoracic Medicine 14 (2), 141-147, 2019 | 4 | 2019 |
| Mass spectrometry-detected MGUS is associated with obesity and other novel modifiable risk factors in a high-risk population DJ Lee, H El-Khoury, AC Tramontano, JB Alberge, J Perry, MI Davis, ... Blood Advances 8 (7), 1737-1746, 2024 | 3 | 2024 |
| Clinical outcomes and evolution of clonal hematopoiesis in patients with newly diagnosed multiple myeloma TH Mouhieddine, C Nzerem, R Redd, A Dunford, M Leventhal, ... Cancer Research Communications 3 (12), 2560-2571, 2023 | 3 | 2023 |
| Medicine in unplanned mass gatherings: A qualitative study of health-care providers’ response and recommendations to Beirut’s protests F Yassine, SB Karroum, R Amine, M Chammas, H Dehaini, H El-Khoury, ... Disaster medicine and public health preparedness 16 (4), 1532-1536, 2022 | 2 | 2022 |
| Single-cell RNA sequencing of rare circulating tumor cells in precursor myeloma patients reveals molecular underpinnings of tumor cell circulation ED Lightbody, DT Firer, R Sklavenitis-Pistofidis, J Tsuji, MP Agius, ... Blood 140 (Supplement 1), 602-603, 2022 | 1 | 2022 |
| High-Throughput Plasma Proteomic Profiling to Identify Candidate High-Risk Disease Biomarkers in Precursor Multiple Myeloma Patients ED Lightbody, H Keshishian, H El-Khoury, AK Dutta, H Barr, J Barbagallo, ... Blood 140 (Supplement 1), 4303-4304, 2022 | 1 | 2022 |
| Persistence of Monoclonal Gammopathies in Serial Samples from a US Population-Based Screening Study H El-Khoury, L Bertamini, JB Alberge, DJ Lee, C Murphy, G Fleming, ... Blood 140 (Supplement 1), 10101-10103, 2022 | 1 | 2022 |
| Abnormal free light chains in individuals with African ancestry screened for monoclonal gammopathy: definition of new reference range accounting for renal function and race L Bertamini, JB Alberge, H El-Khoury, DJ Lee, C Murphy, G Fleming, ... Blood 140 (Supplement 1), 10005-10006, 2022 | 1 | 2022 |
| Prevalence of Monoclonal Gammopathies Including an Age-Related Monoclonal Gammopathy of Indeterminate Potential (MGIP) in a Racially Diverse US Population Screened by Mass … H El-Khoury, DJ Lee, JB Alberge, R Redd, CJ Cea-Curry, J Perry, H Barr, ... | 1 | 2022 |
